Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
The Oncologist
|
June 14, 2015
Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers
Walid L Shaib, Ludmila Katherine Martin, Minsing Choi, et al.
Nature Communications
|
August 19, 2016
PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis
Katherine Martin, James Pritchett, Jessica Llewellyn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 24, 2012
A dose escalation and pharmacodynamic study of triapine and radiation in patients with locally advanced pancreas cancer
Ludmila Katherine Martin, John Grecula, Guang Jia, et al.
Science Signaling
|
March 3, 2021
SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function
Sayyid Raza, Elliot Jokl, James Pritchett, et al.
Scientific Reports
|
August 7, 2019
Publisher Correction: SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis
Varinder S Athwal, James Pritchett, Katherine Martin, et al.
Scientific Reports
|
December 19, 2018
SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis
Varinder S Athwal, James Pritchett, Katherine Martin, et al.
Pancreas
|
March 14, 2014
Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab
Katherine Van Loon, Anne M Espinoza, David R Fogelman, et al.
Cell Reports
|
November 15, 2023
PAK1-dependent mechanotransduction enables myofibroblast nuclear adaptation and chromatin organization during fibrosis
Elliot Jokl, Aoibheann F Mullan, Kara Simpson, et al.
Investigational New Drugs
|
August 1, 2012
A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors
Amir Mortazavi, Yonghua Ling, Ludmila Katherine Martin, et al.
EMBO Molecular Medicine
|
November 8, 2017
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis
Varinder S Athwal, James Pritchett, Jessica Llewellyn, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
The Oncologist
|
June 14, 2015
Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers
Walid L Shaib, Ludmila Katherine Martin, Minsing Choi, et al.
Nature Communications
|
August 19, 2016
PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis
Katherine Martin, James Pritchett, Jessica Llewellyn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 24, 2012
A dose escalation and pharmacodynamic study of triapine and radiation in patients with locally advanced pancreas cancer
Ludmila Katherine Martin, John Grecula, Guang Jia, et al.
Science Signaling
|
March 3, 2021
SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function
Sayyid Raza, Elliot Jokl, James Pritchett, et al.
Scientific Reports
|
August 7, 2019
Publisher Correction: SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis
Varinder S Athwal, James Pritchett, Katherine Martin, et al.
Scientific Reports
|
December 19, 2018
SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis
Varinder S Athwal, James Pritchett, Katherine Martin, et al.
Pancreas
|
March 14, 2014
Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab
Katherine Van Loon, Anne M Espinoza, David R Fogelman, et al.
Cell Reports
|
November 15, 2023
PAK1-dependent mechanotransduction enables myofibroblast nuclear adaptation and chromatin organization during fibrosis
Elliot Jokl, Aoibheann F Mullan, Kara Simpson, et al.
Investigational New Drugs
|
August 1, 2012
A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors
Amir Mortazavi, Yonghua Ling, Ludmila Katherine Martin, et al.
EMBO Molecular Medicine
|
November 8, 2017
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis
Varinder S Athwal, James Pritchett, Jessica Llewellyn, et al.
Page
of 8